To evaluate the comparative efficacy of Nasya by Vrihatjivakadya Taila prepared from Mridu Snehapaka and Madhyama Snehapaka in the management of Ardhavbhedaka w.s.r.migraine.
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- Improvement in MIDAS(Migraine Disability assessment Score)
研究概览
简要总结
The trial is a double blinded randomized clinical trial. The primary aim of the trial is to compare the efficacy of Nasya Karma(nasal administration) with Vrihatjivakadya Taila(oil) of Mridu Snehapaka( lower viscosity) and efficacy of Nasya karma (nasal administration) of Vrihatjivakadya Taila ( oil) with Madhyama Snehapaka (medium viscosity) in the management of Ardhavbhedaka w.s.r. Migraine. Total 100 patients were taken for trial. The patients were randomly divided into two groups of 50 patients each. In group A Nasya Karma with Vrihatjivakadya taila of Mridu Snehapaka in the dose of 6 drops (4.5ml) in each nostril was done for 14 days .In group B Vrihatjivakadya Taila of Madhyama snehapaka in the dose of 6 drops (4.5 ml) in each nostril was done for 14 days . The primary outcome was the improvement in MIDAS score.The patients were finally assessed after 45 days of treatment.
研究设计
- 研究类型
- Interventional
- 分配方式
- Coin toss, Lottery, toss of dice, shuffling cards etc
- 盲法
- Participant and Investigator Blinded
入排标准
- 年龄范围
- 8.00 Year(s) 至 80.00 Year(s)（—）
- 性别
- All
入选标准
- •(1)Patients with clinical signs and symptoms of Ardhavbhedaka.
- •(2)Patients fit for Nasya Karma.
排除标准
- •(1)Patients with severe systemic disorders.
- •(2)Patients of sinusitis, hemiplegic migraine, basilar migraine, retinal migraine and status migranosus.
- •(3)Patients with headache due to any organic lesion and chronic systemic disease.
结局指标
主要结局
Improvement in MIDAS(Migraine Disability assessment Score)
时间窗: 45 days
次要结局
- Relief in symptoms of Ardhavbhedaka.(45 days)